RE-BVS – Piemonte Repository

Sfoglia per AUTORE
IAVARONE M
Collezione AOU Novara

Items : 5

Early Hepatic Decompensation Identifies Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab or Sorafenib at Highest Risk of Death. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2025 Feb 3;31(3):543-550. doi: 10.1158/1078-0432.CCR-24-2582.

2025
AOU Novara

Cabibbo G; Celsa C; Battaglia S; Enea M; Di Maria G; Grova A; Ciccia R; Manfredi GF; Iavarone M; Vogel A; Singal AG; Reig M; Pinato DJ; Cammà C;

Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept. in The Lancet. Oncology / Lancet Oncol. 2023 Jul;24(7):e312-e322. doi: 10.1016/S1470-2045(23)00186-9.

2023
AOU Novara

Vitale A; Cabibbo G; Iavarone M; Viganò L; Pinato DJ; Ponziani FR; Lai Q; Casadei-Gardini A; Celsa C; Galati G; Gambato M; Crocetti L; Renzulli M; Giannini EG; Farinati F; Trevisani F; Cillo U;

Clinical Impact of a Protocol Involving Cone-Beam CT (CBCT), Fusion Imaging and Ablation Volume Prediction in Percutaneous Image-Guided Microwave Ablation in Patients with Hepatocellular Carcinoma Unsuitable for Standard Ultrasound (US) Guidance. in Journal of clinical medicine / J Clin Med. 2023 Dec 9;12(24):7598. doi: 10.3390/jcm12247598.

2023
AOU Novara

Biondetti P; Ierardi AM; Casiraghi E; Caruso A; Grillo P; Carriero S; Lanza C; Angileri SA; Sangiovanni A; Iavarone M; Guzzardi G; Carrafiello G;

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study. in The Lancet. Oncology / Lancet Oncol. 2023 Dec;24(12):1411-1422. doi: 10.1016/S1470-2045(23)00468-0. Epub 2023 Nov 8.

2023
AOU Novara

Zeng Q; Klein C; Caruso S; Maille P; Allende DS; Mínguez B; Iavarone M; Ningarhari M; Casadei-Gardini A; Pedica F; Rimini M; Perbellini R; Boulagnon-Rombi C; Heurgué A; Maggioni M; Rela M; Vij M; Baulande S; Legoix P; Lameiras S; Bruges L; Gnemmi V; Nault JC; Campani C; Rhee H; Park YN; Iñarrairaegui M; Garcia-Porrero G; Argemi J; et alii...

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis. in ESMO open / ESMO Open. 2022 Dec;7(6):100591. doi: 10.1016/j.esmoop.2022.100591. Epub 2022 Oct 6.

2022
AOU Novara

Rimini M; Rimassa L; Ueshima K; Burgio V; Shigeo S; Tada T; Suda G; Yoo C; Cheon J; Pinato DJ; Lonardi S; Scartozzi M; Iavarone M; Di Costanzo GG; Marra F; Soldà C; Tamburini E; Piscaglia F; Masi G; Cabibbo G; Foschi FG; Silletta M; Pressiani T; Nishida N; Iwamoto H; Sakamoto N; Ryoo BY; Chon HJ; Claudia F; et alii...